American Renal Associates Holdings Inc. Daily Stock Analysis

Daily Stock Analysis, ARA, American Renal Associates Holdings Inc, priceseries

American Renal Associates Holdings Inc. Daily Stock Analysis
Stock Information
Open
6.64
Close
6.41
High
6.70
Low
6.38
Previous Close
6.50
Daily Price Gain
-0.09
YTD High
10.35
YTD High Date
Jan 2, 2020
YTD Low
5.57
YTD Low Date
Jun 26, 2020
YTD Price Change
-3.36
YTD Gain
-34.39%
52 Week High
13.80
52 Week High Date
Sep 11, 2019
52 Week Low
5.57
52 Week Low Date
Jun 26, 2020
52 Week Price Change
-1.06
52 Week Gain
-14.19%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 8. 2017
19.90
Mar 2. 2017
22.15
15 Trading Days
11.31%
Link
LONG
Jun 9. 2017
16.98
Jul 5. 2017
18.49
17 Trading Days
8.91%
Link
LONG
Dec 6. 2017
14.34
Jan 29. 2018
18.42
35 Trading Days
28.49%
Link
LONG
Feb 13. 2018
18.79
Mar 20. 2018
22.13
24 Trading Days
17.76%
Link
LONG
Jun 6. 2018
15.01
Jun 25. 2018
16.11
13 Trading Days
7.34%
Link
LONG
Aug 7. 2018
16.77
Aug 30. 2018
21.14
17 Trading Days
26.05%
Link
LONG
Feb 14. 2019
12.21
Feb 27. 2019
12.83
8 Trading Days
5.10%
Link
LONG
Apr 10. 2019
6.69
Apr 11. 2019
7.33
1 Trading Days
9.49%
Link
LONG
Sep 5. 2019
7.54
Sep 16. 2019
9.06
7 Trading Days
20.11%
Link
LONG
Oct 24. 2019
7.40
Nov 7. 2019
8.43
10 Trading Days
13.97%
Link
Company Information
Stock Symbol
ARA
Exchange
NYSE
Company URL
http://www.americanrenal.com
Company Phone
978-922-3080
CEO
Joseph A. Carlucci
Headquarters
Massachusetts
Business Address
AMERICAN RENAL HOLDINGS, INC., 500 CUMMINGS CENTER, SUITE 6550, BEVERLY, MA 01915
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001498068
About

American Renal Associates Holdings, Inc. operates with interest in providing kidney dialysis services. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure. Its offerings include Autonomy, it is dialysis facility giving decision-making and control; Quality Patient Care, consist of a physician-driven organization, patients receive dialysis treatments; Operational Management, its operating expertise and core competencies are economic advantage; ARA Beacon, which is designed to alleviate administrative responsibilities and assist hospital staff by providing a discharge coordinator; and Acute Inpatient Dialysis Services, includes trained dialysis nurses and technicians, water treatment systems and 24/7 coverage. The company was founded by Joseph A. Carlucci, Christopher T. Ford and Syed T. Kamal in 1999 and is headquartered in Beverly, MA.

Description

American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States focused exclusively on joint venture partnerships with physicians. The company, through its subsidiaries, owns and operates kidney dialysis facilities to patients suffering from chronic kidney failure or end stage renal disease (ESRD). As of March 31, 2016, it owned and operated 194 dialysis clinics in 25 states and the District of Columbia. The company was formerly known as C.P. Atlas Holdings, Inc. and changed its name to American Renal Associates Holdings, Inc. in February 2011. American Renal Associates Holdings, Inc. was founded in 1999 and is headquartered in Beverly, Massachusetts.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading